Ralph Schiess
Amministratore Delegato presso ONCONETIX, INC.
Patrimonio netto: 45 048 $ in data 30/06/2024
Profilo
Ralph Schiess is the founder and Chief Executive Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Executive & Science Officer at Onconetix, Inc., a position he started in 2023.
Dr. Schiess has a graduate degree from the University of Zurich and a doctorate degree from the Swiss Federal Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ONCONETIX INC
1.21% | 05/04/2024 | 269 749 ( 1.21% ) | 45 048 $ | 30/06/2024 |
Posizioni attive di Ralph Schiess
| Società | Posizione | Inizio |
|---|---|---|
| ONCONETIX, INC. | Amministratore Delegato | 12/01/2024 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Amministratore Delegato | 01/01/2010 |
Formazione di Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Ralph Schiess
